Newborn Screening by Tandem Mass Spectrometry
نویسندگان
چکیده
منابع مشابه
Newborn screening by tandem mass spectrometry: gaining experience.
Major expansion of newborn screening for inherited metabolic disorders is taking place across the US and around the world as newer analytical technology is applied. Historically, each disorder to be screened required a separate test with associated costs and requirement for a portion of the dried-blood-spot specimen from a heel stick. This limitation of the existing tests was partially responsi...
متن کاملNewborn screening by tandem mass spectrometry: ethical and social issues.
Emerging technologies like Tandem Mass Spectrometry (TMS) enable multiple tests on a single blood sample and allow the expansion of Newborn Screening (NBS) to include various metabolic diseases. Introducing TMS for NBS raises important social and ethical questions: what are the criteria for adding disorders to screening panels? What evidence justifies expansion of screening? How can equity in N...
متن کاملNewborn screening by tandem mass spectrometry: a new era.
Soon after Guthrie (1) expanded newborn screening by adding galactosemia, maple syrup urine disease (MSUD), and homocystinuria to the original screening for phenylketonuria (PKU), he realized that screening would be more efficient and comprehensive if a single assay could be used to detect several disorders rather than the system of a separate bacterial assay for each disorder that he had devel...
متن کاملNewborn screening by tandem mass spectrometry (MS-MS)
Newborn screening for selected inherited metabolic disorders is a well-established public health measure in most developed countries [1/. The purpose is to identify and properly diagnose individuals in the neonatal period to enable early medical intervention to prevent or significantly reduce clinical symptoms such as mental retardation. Some of the basic criteria for determining which inherite...
متن کاملNewborn screening for sickle cell disease using tandem mass spectrometry.
BACKGROUND Neonatal screening programs for sickle cell disease are now widespread in North American and European countries. Most programs apply isoelectric focusing or HPLC to detect hemoglobin variants. Because tandem mass spectrometry (MS/MS) is being used for screening of inherited metabolic disorders and allows protein identification, it was worth testing for hemoglobinopathy screening. M...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Chemistry
سال: 2001
ISSN: 0009-9147,1530-8561
DOI: 10.1093/clinchem/47.11.1937